Screening for germ line p53 mutations in children with malignant tumors and a family history of cancerBRUGIERES, L; GARDES, M; FEUNTEUM, J et al.Cancer research (Baltimore). 1993, Vol 53, Num 3, pp 452-455, issn 0008-5472Article

Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation : a study in 136 childrenMERESSE, V; HARTMANN, O; VASSAL, G et al.Bone marrow transplantation (Basingstoke). 1992, Vol 10, Num 2, pp 135-141, issn 0268-3369Article

Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent Breast cancer patientsVIENS, P; CHABANNON, C; XU, Z. X et al.Journal of clinical oncology. 2002, Vol 20, Num 1, pp 24-36, issn 0732-183XArticle

Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients : A randomized, controlled trialFACON, T; HAROUSSEAU, J.-L; GUILHOT, F et al.Blood. 1999, Vol 94, Num 4, pp 1218-1225, issn 0006-4971Article

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (Filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastomaMICHON, J. M; HARTMANN, O; LEMERLE, J et al.European journal of cancer (1990). 1998, Vol 34, Num 7, pp 1063-1069, issn 0959-8049Article

In vivo induction of functional FcγRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF)MICHON, J. M; GEY, A; MOUTEL, S et al.British journal of haematology. 1998, Vol 100, Num 3, pp 550-556, issn 0007-1048Article

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas : Hematologic recovery and costs : A randomized, controlled trialHARTMANN, O; LE CORROLLER, A. G; COZE, C et al.Annals of internal medicine. 1997, Vol 126, Num 8, pp 600-607, issn 0003-4819Article

Phase I-II study of interleukin-2 after high-dose chemotherapy and autologour bone marrow transplantation in poorly responding neuroblastomaVALTEAU-COAUNET, D; RUBIE, H; MERESSE, V et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 4, pp 515-520, issn 0268-3369Article

Solid malignant neoplasms after childhood irradiation : decrease of the relative risk with time after irradiation = Tumeurs malignes solides survenant après irradiation dans l'enfance : décroissance du risque relatif au cours du temps suivant l'irradiationDE VATHAIRE, F; AKHTAR SHAMSALDIN; DIALLO, I et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1995, Vol 318, Num 4, pp 483-490, issn 0764-4469Article

Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiationBECK, M. N; MERESSE, V; HARTMANN, O et al.Bone marrow transplantation (Basingstoke). 1995, Vol 16, Num 6, pp 771-775, issn 0268-3369Article

Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma : a phase II study from the Société Française d'Oncologie PédiatriqueMERESSE, V; VASSAL, G; HARTMANN, O et al.Journal of clinical oncology. 1993, Vol 11, Num 4, pp 630-637, issn 0732-183XArticle